Katja Rosenkranz - Profile and Investment Details

Investor Profile

Katja Rosenkranz is a Venture Capital, Private Equity Firm based in Flanders, Belgium with a diverse investment portfolio that includes companies such as Animab, Aphea.Bio, Precirix, Confo Therapeutics, Oxular, Biodol Therapeutics, HoramaOrionis Biosciences, Syndesi Therapeutics, ExeVir Bio, RootWave, OCTIMET Oncology, Augustine Therapeutics, AgomAb Therapeutics, . Over time, Katja Rosenkranz has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Katja Rosenkranz is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Chemical, Life Science, Information Technology (IT), Biotechnology, Agriculture, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Katja Rosenkranz, as their portfolio suggests a familiarity and interest in this area.

Understanding Katja Rosenkranz’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.